https://scholars.lib.ntu.edu.tw/handle/123456789/568464
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.author | PEI-JER CHEN | en_US |
dc.contributor.author | Wu T.-C. | en_US |
dc.date.accessioned | 2021-07-03T03:34:18Z | - |
dc.date.available | 2021-07-03T03:34:18Z | - |
dc.date.issued | 2013 | - |
dc.identifier.issn | 2045-3701 | - |
dc.identifier.uri | https://www.scopus.com/inward/record.uri?eid=2-s2.0-84984588834&doi=10.1186%2f2045-3701-3-2&partnerID=40&md5=8789b71e3de41fd924e3632f86524bd4 | - |
dc.identifier.uri | https://scholars.lib.ntu.edu.tw/handle/123456789/568464 | - |
dc.description.abstract | Following the successful cloning of receptor for SARS coronavirus a few years ago, Dr. Wenhui Li and colleagues raised attention again by publishing a possible receptor for hepatitis B virus in eLife. We will briefly review the significance of this finding and the future prospects of hepatitis B research. ? 2013 Chen and Wu; licensee BioMed Central Ltd. | - |
dc.publisher | BioMed Central Ltd. | - |
dc.relation.ispartof | Cell and Bioscience | - |
dc.subject.classification | [SDGs]SDG3 | - |
dc.title | One step closer to an experimental infection system for Hepatitis B Virus? --- the identification of sodium taurocholate cotransporting peptide as a viral receptor | en_US |
dc.type | Note | en |
dc.identifier.doi | 10.1186/2045-3701-3-2 | - |
dc.identifier.scopus | 2-s2.0-84984588834 | - |
dc.relation.pages | 2 | - |
dc.relation.journalvolume | 3 | - |
dc.relation.journalissue | 1 | - |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
item.openairetype | Note | - |
item.grantfulltext | none | - |
item.cerifentitytype | Publications | - |
item.fulltext | no fulltext | - |
crisitem.author.dept | Clinical Medicine | - |
crisitem.author.orcid | 0000-0001-8316-3785 | - |
crisitem.author.parentorg | College of Medicine | - |
顯示於: | 臨床醫學研究所 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。